Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rubin

Showing results (991-1000 of 1,202) with videos related to

Pageof 121
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1997
Prospective randomized trial of lisofylline for the prevention of toxicities of high-dose interleukin 2 therapy in advanced renal cancer and malignant melanomaK Margolin, M Atkins, J Sparano, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 22, 2013
Early trends from the Study to Evaluate the Prospective Payment System Impact on Small Dialysis Organizations (STEPPS)Steven M Brunelli, Keri L Monda, John M Burkart, et al.
The New England Journal of Medicine|March 22, 2002
Bosentan therapy for pulmonary arterial hypertensionLewis J Rubin, David B Badesch, Robyn J Barst, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1989
Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo ClinicJ A Laurie, C G Moertel, T R Fleming, et al.
Journal of the American College of Cardiology|August 2, 2005
Ambrisentan therapy for pulmonary arterial hypertensionNazzareno Galié, David Badesch, Ronald Oudiz, et al.
Leukemia Research|July 1, 1996
Evaluation of monoclonal antibody-mediated anti-acute myeloid leukemia immunotherapy in a SCID/hu modelR K Zhong, A D Donnenberg, L D Shultz, et al.
American Journal of Otolaryngology|April 11, 2024
Metastatic merkel cell carcinoma to the thyroid gland: Case report and review of the literatureSalmaan Sayeed, Danielle Kapustin, Samuel J Rubin, et al.
Artificial Intelligence in Medicine|November 18, 2024
Domain generalization for enhanced predictions of hospital readmission on unseen domains among patients with diabetesAmeen Abdel Hai, Mark G Weiner, Alice Livshits, et al.
American Journal of Respiratory and Critical Care Medicine|March 19, 2002
Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trialGerald Simonneau, Robyn J Barst, Nazzareno Galie, et al.
The New England Journal of Medicine|July 26, 2013
Riociguat for the treatment of pulmonary arterial hypertensionHossein-Ardeschir Ghofrani, Nazzareno Galiè, Friedrich Grimminger, et al.
Pageof 121

Showing results (991-1000 of 1,202) with videos related to

Sort By:
Pageof 121
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1997
Prospective randomized trial of lisofylline for the prevention of toxicities of high-dose interleukin 2 therapy in advanced renal cancer and malignant melanomaK Margolin, M Atkins, J Sparano, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 22, 2013
Early trends from the Study to Evaluate the Prospective Payment System Impact on Small Dialysis Organizations (STEPPS)Steven M Brunelli, Keri L Monda, John M Burkart, et al.
The New England Journal of Medicine|March 22, 2002
Bosentan therapy for pulmonary arterial hypertensionLewis J Rubin, David B Badesch, Robyn J Barst, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1989
Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo ClinicJ A Laurie, C G Moertel, T R Fleming, et al.
Journal of the American College of Cardiology|August 2, 2005
Ambrisentan therapy for pulmonary arterial hypertensionNazzareno Galié, David Badesch, Ronald Oudiz, et al.
Leukemia Research|July 1, 1996
Evaluation of monoclonal antibody-mediated anti-acute myeloid leukemia immunotherapy in a SCID/hu modelR K Zhong, A D Donnenberg, L D Shultz, et al.
American Journal of Otolaryngology|April 11, 2024
Metastatic merkel cell carcinoma to the thyroid gland: Case report and review of the literatureSalmaan Sayeed, Danielle Kapustin, Samuel J Rubin, et al.
Artificial Intelligence in Medicine|November 18, 2024
Domain generalization for enhanced predictions of hospital readmission on unseen domains among patients with diabetesAmeen Abdel Hai, Mark G Weiner, Alice Livshits, et al.
American Journal of Respiratory and Critical Care Medicine|March 19, 2002
Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trialGerald Simonneau, Robyn J Barst, Nazzareno Galie, et al.
The New England Journal of Medicine|July 26, 2013
Riociguat for the treatment of pulmonary arterial hypertensionHossein-Ardeschir Ghofrani, Nazzareno Galiè, Friedrich Grimminger, et al.
Pageof 121